Kidney Failure
New federal model for increasing kidney transplants begins July 1
CMS and HHS finalized a federal rule aimed at increasing the number of kidney transplants and addressing disparities among potential organ recipients, according to a CMS press release.
Tolvaptan may slow disease progression, kidney failure in autosomal dominant PKD
Tolvaptan may slow disease progression and delay kidney failure in young adults with autosomal dominant polycystic kidney disease, according to results of a pooled database study.
VIDEO: Obesity presents obstacles to kidney care
In this video exclusive, Deidra C. Crews, MD, ScM, FASN, president of the American Society of Nephrology discusses connections between kidney disease and obesity.
Black adults who develop CKD young may be at higher risk for eGFR decline vs. white adults
SAN DIEGO — Black veterans who develop chronic kidney disease at a young age may be at a higher risk for eGFR decline than white veterans, according to data presented at Kidney Week.
SGLT2 inhibitors may delay kidney complications better than other anti-diabetes agents
SGLT2 inhibitors and GLP-1 were more effective than dipeptidyl peptidase-4 inhibitors and sulfonylurea kidney complications .
To reach optimal kidney care, funding for innovation is necessary
“The historic underfunding of the ESRD payment system has created disincentives for the development of new drugs, biologicals, devices and innovative treatment options ... ”
Cell therapy, new PD devices, bioartificial kidneys set a new direction for kidney care
In an editorial published in the Clinical Journal of the American Society of Nephrology, nephrologists Mark E. Rosenberg, MD, and Tod Ibrahim, MD, detailed problems the specialty may face in the coming decade.
Canagliflozin tied to improved iron, hemoglobin levels with type 2 diabetes, CKD
Canagliflozin was associated with increased iron utilization and improved hemoglobin levels for adults with type 2 diabetes and chronic kidney disease, according to data published in Nephrology Dialysis Transplantation.
Follow the twists and turns toward better kidney care — more on the road ahead
After 35 years, I am stepping down as editor-in-chief for Healio | Nephrology News & Issues. Retirement awaits, but I have pledged to myself to keep active.
Rate of kidney replacement therapy for primary glomerular disease varies by country
Rate of kidney replacement therapy for end-stage kidney disease due to primary glomerular disease varies between European countries and was highest for immunoglobulin A nephropathy and focal segmental glomerulosclerosis, study data show.